Cardiology

Software visualizes the heart for doctors

Siemens developed a procedure for angioplasty which supports doctors to make interventions at the heart faster and more precise. With angioplasty doctors open up an artery, potentially staving off more invasive procedures ...

Cardiology

Results of DUTCH PEERS (TWENTE II) trial reported

Results of the DUTCH PEERS (TWENTE II) clinical trial demonstrate comparable safety and efficacy of two third-generation permanent polymer-based drug-eluting stents with low rates of adverse clinical events and establish ...

Cardiology

Results of the ARCTIC-INTERRUPTION trial presented

According to a new study, patients that do not experience a major cardiac event in the first year after receiving drug-eluting stent (DES) may not need to receive prolonged dual antiplatelet therapy (DAPT). Results from the ...

Cardiology

Procedural results from the RIBS V trial presented

A clinical trial comparing the use of drug-eluting stents (DES) and drug-eluting balloons (DEB) in treating in-stent restenosis (ISR) from bare metal stents found that both techniques yielded positive long term outcomes. ...

Cardiology

Results of the TRYTON trial presented

A clinical trial designed to measure the effectiveness of using a dedicated side branch-covering bare metal stent in true bifurcation coronary lesions found that that the strategy was safe, but the results did not establish ...

Cardiology

Results of the SORT-OUT VI trial presented

A new study found that both drug-eluting stents (DES) with biocompatible polymers and DES with biodegradable polymers were associated with low major adverse coronary events, demonstrating the non-inferiority of the biocompatible ...

page 19 from 34